Avinger Closes $22.5M Series C

Avinger Inc., a maker of multi-functional catheters for treating patients with Peripheral Artery Disease, has closed on $22.5 million in Series C financing. “All existing major investors” participated in the round, with new investors contributing approximately $6 million, the company said in a written release. The firm did not name investors.

9 January 2012•2 mins read
Feature image
LinkedInXEmail
LinkedInXEmail